Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHD finger protein 5A pseudogene is a nonfunctional DNA sequence in the human genome derived from the protein-coding gene PHF5A through retrotransposition or gene duplication processes. Pseudogenes like this one typically do not code for proteins and lack biological activity; they can be identified by sequence similarity to functional genes but accumulate disabling mutations and are incapable of producing functional proteins. Pseudogenes are generally classified as "junk DNA," although some rare pseudogenes have been found to exert regulatory roles through their RNA transcripts. However, there is no evidence the PHF5A pseudogene holds such a role. It is not considered a molecular therapeutic target or a clinically actionable biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHD finger protein 5A pseudogene (PHF5A pseudogene).